LINDE PLC vs Solstice Advanced Materials Inc., two Chemicals stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where LIN and SOLS diverge most: on ev/ebitda, LIN reads 20.8 and SOLS reads 58.1; on p/s, LIN reads 7.13 and SOLS reads 2.59. The rest of the comparable metrics sit closer together. What LIN's price implies is a bet that sits within the historical range (whole-company basis). The bull and bear cases for each are in their full reports below.
| Metric | LIN | SOLS |
|---|---|---|
| Price | $529.65 | $61.31 |
| Market cap | $247.0B | $9.8B |
| Sector | Chemicals | Chemicals |
| Stage | Mature | Mature |
| Implied growth (priced in) | +22.3% | — |
| P/E | 35.1 | — |
| P/B | 6.16 | 6.57 |
| P/S | 7.13 | 2.59 |
| EV/EBITDA | 20.8 | 58.1 |
| Revenue growth | +5.0% | +8.7% |
| Operating margin | 27.8% | — |
| Net margin | 20.4% | 8.9% |
| Return on equity | 17.7% | 22.6% |
| Return on assets | 8.2% | 5.8% |
| Return on invested capital | 10.9% | — |
| FCF yield | 2.1% | 3.5% |
| Dividend yield | 1.1% | — |
| Debt / equity | 0.66 | 1.33 |
| Current ratio | 0.83 | 1.43 |
| Altman Z (solvency) | 3.95 | 2.21 |
| Piotroski F (quality) | 8 / 9 | 7 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.